25 XP   0   0   10

Longboard Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Longboard Pharmaceuticals Inc together

PenkeI guess you are interested in Longboard Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Longboard Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Longboard Pharmaceuticals Inc

I send you an email if I find something interesting about Longboard Pharmaceuticals Inc.

Quick analysis of Longboard Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Longboard Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.22
Expected worth in 1 year
$0.61
How sure are you?
23.1%

+ What do you gain per year?

Total Gains per Share
$-0.61
Return On Investment
-3.5%

For what price can you sell your share?

Current Price per Share
$17.44
Expected price per share
$8.98 - $20.89
How sure are you?
50%

1. Valuation of Longboard Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$17.44

Intrinsic Value Per Share

$-21.75 - $-25.71

Total Value Per Share

$-20.53 - $-24.49

2. Growth of Longboard Pharmaceuticals Inc (5 min.)




Is Longboard Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$40.9m$77.5m-$21.7m-39.0%

How much money is Longboard Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$13.4m-$10.8m-$2.6m-19.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Longboard Pharmaceuticals Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#501 / 1016

Most Revenue
#760 / 1016

Most Profit
#612 / 1016

Most Efficient
#204 / 1016

What can you expect buying and holding a share of Longboard Pharmaceuticals Inc? (5 min.)

Welcome investor! Longboard Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Longboard Pharmaceuticals Inc.

What can you expect buying and holding a share of Longboard Pharmaceuticals Inc?

First you should know what it really means to hold a share of Longboard Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Longboard Pharmaceuticals Inc is $17.44. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Longboard Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Longboard Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.22. Based on the TTM, the Book Value Change Per Share is $-0.15 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.31 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Longboard Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.45-2.6%-0.40-2.3%-0.33-1.9%-0.31-1.8%-0.31-1.8%
Usd Book Value Change Per Share-0.33-1.9%-0.15-0.9%-0.31-1.8%0.090.5%0.090.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.33-1.9%-0.15-0.9%-0.31-1.8%0.090.5%0.090.5%
Usd Price Per Share6.03-5.74-3.85-5.97-5.97-
Price to Earnings Ratio-3.37--3.51--3.01--5.97--5.97-
Price-to-Total Gains Ratio-18.22--13.49--12.57--25.86--25.86-
Price to Book Ratio4.95-3.66-1.67-2.52-2.52-
Price-to-Total Gains Ratio-18.22--13.49--12.57--25.86--25.86-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share17.44
Number of shares57
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.150.09
Usd Total Gains Per Share-0.150.09
Gains per Quarter (57 shares)-8.725.34
Gains per Year (57 shares)-34.8621.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-35-4502111
20-70-8004332
30-105-11506453
40-139-15008574
50-174-185010795
60-209-2200128116
70-244-2550150137
80-279-2900171158
90-314-3250192179
100-349-3600214200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.013.00.00.0%0.013.00.00.0%0.013.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%3.010.00.023.1%3.010.00.023.1%3.010.00.023.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.013.00.0%0.00.013.00.0%0.00.013.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%3.010.00.023.1%3.010.00.023.1%3.010.00.023.1%

Fundamentals of Longboard Pharmaceuticals Inc

About Longboard Pharmaceuticals Inc

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. The company develops bexicaserin (LP352), which has completed Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. It also develops LP659, an S1P receptor modulator for the treatment of neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

Fundamental data was last updated by Penke on 2024-04-11 13:08:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Longboard Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Longboard Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Longboard Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Longboard Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--199.6%+199.6%
TTM--213.0%+213.0%
YOY--279.3%+279.3%
5Y--438.4%+438.4%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient Longboard Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Longboard Pharmaceuticals Inc to the Biotechnology industry mean.
  • -29.7% Return on Assets means that Longboard Pharmaceuticals Inc generated $-0.30 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Longboard Pharmaceuticals Inc:

  • The MRQ is -29.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -22.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-29.7%TTM-22.0%-7.6%
TTM-22.0%YOY-12.9%-9.1%
TTM-22.0%5Y-14.0%-8.0%
5Y-14.0%10Y-14.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.7%-13.5%-16.2%
TTM-22.0%-12.9%-9.1%
YOY-12.9%-11.8%-1.1%
5Y-14.0%-14.1%+0.1%
10Y-14.0%-16.0%+2.0%
1.1.3. Return on Equity

Shows how efficient Longboard Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Longboard Pharmaceuticals Inc to the Biotechnology industry mean.
  • -36.7% Return on Equity means Longboard Pharmaceuticals Inc generated $-0.37 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Longboard Pharmaceuticals Inc:

  • The MRQ is -36.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -25.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-36.7%TTM-25.6%-11.1%
TTM-25.6%YOY-14.4%-11.3%
TTM-25.6%5Y-15.7%-10.0%
5Y-15.7%10Y-15.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-36.7%-16.9%-19.8%
TTM-25.6%-16.1%-9.5%
YOY-14.4%-15.1%+0.7%
5Y-15.7%-19.9%+4.2%
10Y-15.7%-20.9%+5.2%

1.2. Operating Efficiency of Longboard Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Longboard Pharmaceuticals Inc is operating .

  • Measures how much profit Longboard Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Longboard Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Longboard Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY--288.4%+288.4%
5Y--477.4%+477.4%
10Y--625.6%+625.6%
1.2.2. Operating Ratio

Measures how efficient Longboard Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Longboard Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.090-3.090
TTM-3.264-3.264
YOY-3.783-3.783
5Y-5.679-5.679
10Y-7.894-7.894

1.3. Liquidity of Longboard Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Longboard Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.14 means the company has $5.14 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Longboard Pharmaceuticals Inc:

  • The MRQ is 5.138. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.259. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.138TTM8.259-3.121
TTM8.259YOY11.172-2.913
TTM8.2595Y16.263-8.003
5Y16.26310Y16.2630.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1383.914+1.224
TTM8.2594.220+4.039
YOY11.1725.388+5.784
5Y16.2636.045+10.218
10Y16.2636.406+9.857
1.3.2. Quick Ratio

Measures if Longboard Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Longboard Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 8.46 means the company can pay off $8.46 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Longboard Pharmaceuticals Inc:

  • The MRQ is 8.458. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 13.160. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.458TTM13.160-4.702
TTM13.160YOY18.471-5.311
TTM13.1605Y21.781-8.621
5Y21.78110Y21.7810.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.4583.572+4.886
TTM13.1603.998+9.162
YOY18.4715.390+13.081
5Y21.7815.969+15.812
10Y21.7816.287+15.494

1.4. Solvency of Longboard Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Longboard Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Longboard Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.19 means that Longboard Pharmaceuticals Inc assets are financed with 19.3% credit (debt) and the remaining percentage (100% - 19.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Longboard Pharmaceuticals Inc:

  • The MRQ is 0.193. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.131. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.193TTM0.131+0.061
TTM0.131YOY0.097+0.035
TTM0.1315Y0.086+0.046
5Y0.08610Y0.0860.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1930.336-0.143
TTM0.1310.334-0.203
YOY0.0970.269-0.172
5Y0.0860.366-0.280
10Y0.0860.390-0.304
1.4.2. Debt to Equity Ratio

Measures if Longboard Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Longboard Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 23.9% means that company has $0.24 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Longboard Pharmaceuticals Inc:

  • The MRQ is 0.239. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.154. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.239TTM0.154+0.085
TTM0.154YOY0.108+0.046
TTM0.1545Y0.097+0.057
5Y0.09710Y0.0970.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2390.382-0.143
TTM0.1540.396-0.242
YOY0.1080.335-0.227
5Y0.0970.434-0.337
10Y0.0970.465-0.368

2. Market Valuation of Longboard Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Longboard Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Longboard Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of -3.37 means the investor is paying $-3.37 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Longboard Pharmaceuticals Inc:

  • The EOD is -9.744. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.369. Based on the earnings, the company is expensive. -2
  • The TTM is -3.507. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.744MRQ-3.369-6.375
MRQ-3.369TTM-3.507+0.138
TTM-3.507YOY-3.014-0.493
TTM-3.5075Y-5.968+2.461
5Y-5.96810Y-5.9680.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.744-2.259-7.485
MRQ-3.369-2.569-0.800
TTM-3.507-2.664-0.843
YOY-3.014-4.120+1.106
5Y-5.968-6.258+0.290
10Y-5.968-6.171+0.203
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Longboard Pharmaceuticals Inc:

  • The EOD is -13.283. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.593. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.815. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.283MRQ-4.593-8.690
MRQ-4.593TTM-3.815-0.777
TTM-3.815YOY-3.381-0.434
TTM-3.8155Y-6.212+2.397
5Y-6.21210Y-6.2120.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-13.283-2.924-10.359
MRQ-4.593-3.246-1.347
TTM-3.815-3.488-0.327
YOY-3.381-5.620+2.239
5Y-6.212-8.315+2.103
10Y-6.212-8.826+2.614
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Longboard Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.95 means the investor is paying $4.95 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Longboard Pharmaceuticals Inc:

  • The EOD is 14.318. Based on the equity, the company is expensive. -2
  • The MRQ is 4.950. Based on the equity, the company is fair priced.
  • The TTM is 3.663. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD14.318MRQ4.950+9.367
MRQ4.950TTM3.663+1.288
TTM3.663YOY1.670+1.993
TTM3.6635Y2.522+1.140
5Y2.52210Y2.5220.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD14.3181.851+12.467
MRQ4.9502.090+2.860
TTM3.6632.095+1.568
YOY1.6702.844-1.174
5Y2.5223.466-0.944
10Y2.5223.815-1.293
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Longboard Pharmaceuticals Inc.

3.1. Institutions holding Longboard Pharmaceuticals Inc

Institutions are holding 63.632% of the shares of Longboard Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Cormorant Asset Management, LLC6.53340.6777235314100
2023-12-31FMR Inc4.57980.00081649503-463570-21.9382
2023-12-31T. Rowe Price Associates, Inc.4.51720.00131626982-145366-8.2019
2023-12-31Farallon Capital Management, L.L.C.4.33260.0467156050000
2023-12-31Polar Capital Holdings PLC2.77640.0369100000000
2023-12-31Ikarian Capital, LLC2.71940.55397946246536190.5194
2023-12-31Integral Health Asset Management, LLC2.49880.739190000014000018.4211
2023-12-31BlackRock Inc2.41520.00018698798404310.6947
2023-09-30Point72 Asset Management, L.P.2.29060.013482500000
2023-12-31Vanguard Group Inc2.18350.000178643353600.6862
2023-12-31JPMorgan Chase & Co1.48460.000353471612140.2276
2023-12-31Jennison Associates LLC1.3350.00224808284808280
2023-12-31Parkman Healthcare Partners LLC1.19360.36514298927393520.7708
2023-12-31Geode Capital Management, LLC0.92920.000233466129720.896
2023-12-31Ensign Peak Advisors Inc0.83620.00363011613011610
2023-12-31State Street Corporation0.82870.000129846746001.5653
2023-12-31BOOTHBAY FUND MANAGEMENT, LLC0.64270.0356231471118857105.5437
2023-12-31CIBC Global Asset Management Inc0.58910.00482121786760746.7639
2023-12-31Northern Trust Corp0.42430.00021528311592211.6296
2023-12-31Junked Platinum Investment Management Ltd0.35270.03111270481270480
Total 43.4632.512315654153+1279972+8.2%

3.2. Funds holding Longboard Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Fidelity Select Biotechnology4.57580.8024177848948503437.4991
2023-12-31HBM Healthcare Investments AG Ord3.46810.4071134796700
2024-02-29Polar Capital Biotech S Inc3.21611.57661250000293212.402
2024-02-29Vanguard Total Stock Mkt Idx Inv2.15810.001283880100
2023-12-31T. Rowe Price New Horizons1.96360.0186763196-2439-0.3186
2023-12-31US Small-Cap Growth II Equity Comp1.96360.0185763196-2439-0.3186
2024-03-28iShares Russell 2000 ETF1.55550.01996045922910.0482
2023-12-31T. Rowe Price Health Sciences1.40210.0223544951-141171-20.5752
2023-12-31Fidelity Global Innovators Cl F1.38880.0438539798-2573-0.4744
2024-02-29Fidelity Advisor Biotechnology I1.14740.556244597010670031.4499
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.95410.0081370851-411-0.1107
2024-02-29Wellington Global Hlthcr Eq USD G Ac0.94830.3111368576-10765-2.8378
2024-02-29PGIM Jennison Health Sciences Z0.87010.417633818400
2024-03-31Jennison Health Sciences Equity0.87010.39593381843381840
2024-01-31Fidelity Series Small Cap Opps0.82740.1323216003216000
2024-02-29Fidelity VIP Mid Cap Initial0.55240.065221470000
2023-12-31Renaissance Global Health Care0.54590.241221217800
2024-02-29JPMorgan US Small Company L0.50910.447419788500
2024-01-31Fidelity Stock Selector Small Cap0.42630.13281657001657000
2024-01-31Fidelity Small Cap Index0.40740.0136158331125088.5775
Total 29.75025.631511563149+1299540+11.2%

3.3. Insider Transactions

Insiders are holding 1.135% of the shares of Longboard Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-25Arena Pharmaceuticals IncSELL397854024.25

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Longboard Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.331-0.153-54%-0.311-6%0.094-453%0.094-453%
Book Value Per Share--1.2181.661-27%2.309-47%2.378-49%2.378-49%
Current Ratio--5.1388.259-38%11.172-54%16.263-68%16.263-68%
Debt To Asset Ratio--0.1930.131+47%0.097+99%0.086+124%0.086+124%
Debt To Equity Ratio--0.2390.154+56%0.108+121%0.097+147%0.097+147%
Dividend Per Share----0%-0%-0%-0%
Eps---0.447-0.405-9%-0.327-27%-0.312-30%-0.312-30%
Free Cash Flow Per Share---0.328-0.379+15%-0.283-14%-0.264-20%-0.264-20%
Free Cash Flow To Equity Per Share---0.239-0.154-36%-0.290+21%0.106-325%0.106-325%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---25.708--------
Intrinsic Value_10Y_min---21.747--------
Intrinsic Value_1Y_max---1.339--------
Intrinsic Value_1Y_min---1.315--------
Intrinsic Value_3Y_max---4.966--------
Intrinsic Value_3Y_min---4.722--------
Intrinsic Value_5Y_max---9.730--------
Intrinsic Value_5Y_min---8.950--------
Market Cap585922960.000+65%202586895.000192675927.500+5%129430516.250+57%200493574.615+1%200493574.615+1%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio14.318+65%4.9503.663+35%1.670+196%2.522+96%2.522+96%
Pe Ratio-9.744-189%-3.369-3.507+4%-3.014-11%-5.968+77%-5.968+77%
Price Per Share17.440+65%6.0305.735+5%3.853+57%5.968+1%5.968+1%
Price To Free Cash Flow Ratio-13.283-189%-4.593-3.815-17%-3.381-26%-6.212+35%-6.212+35%
Price To Total Gains Ratio-52.686-189%-18.217-13.492-26%-12.573-31%-25.862+42%-25.862+42%
Quick Ratio--8.45813.160-36%18.471-54%21.781-61%21.781-61%
Return On Assets---0.297-0.220-26%-0.129-56%-0.140-53%-0.140-53%
Return On Equity---0.367-0.256-30%-0.144-61%-0.157-57%-0.157-57%
Total Gains Per Share---0.331-0.153-54%-0.311-6%0.094-453%0.094-453%
Usd Book Value--40923000.00055802000.000-27%77585250.000-47%79897076.923-49%79897076.923-49%
Usd Book Value Change Per Share---0.331-0.153-54%-0.311-6%0.094-453%0.094-453%
Usd Book Value Per Share--1.2181.661-27%2.309-47%2.378-49%2.378-49%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.447-0.405-9%-0.327-27%-0.312-30%-0.312-30%
Usd Free Cash Flow---11028000.000-12717000.000+15%-9515750.000-14%-8853692.308-20%-8853692.308-20%
Usd Free Cash Flow Per Share---0.328-0.379+15%-0.283-14%-0.264-20%-0.264-20%
Usd Free Cash Flow To Equity Per Share---0.239-0.154-36%-0.290+21%0.106-325%0.106-325%
Usd Market Cap585922960.000+65%202586895.000192675927.500+5%129430516.250+57%200493574.615+1%200493574.615+1%
Usd Price Per Share17.440+65%6.0305.735+5%3.853+57%5.968+1%5.968+1%
Usd Profit---15033000.000-13479000.000-10%-10818750.000-28%-10392076.923-31%-10392076.923-31%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.331-0.153-54%-0.311-6%0.094-453%0.094-453%
 EOD+5 -3MRQTTM+7 -22YOY+7 -225Y+4 -2510Y+4 -25

4.2. Fundamental Score

Let's check the fundamental score of Longboard Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.744
Price to Book Ratio (EOD)Between0-114.318
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.458
Current Ratio (MRQ)Greater than15.138
Debt to Asset Ratio (MRQ)Less than10.193
Debt to Equity Ratio (MRQ)Less than10.239
Return on Equity (MRQ)Greater than0.15-0.367
Return on Assets (MRQ)Greater than0.05-0.297
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Longboard Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.357
Ma 20Greater thanMa 5019.083
Ma 50Greater thanMa 10020.081
Ma 100Greater thanMa 20017.276
OpenGreater thanClose17.690
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets50,697
Total Liabilities9,774
Total Stockholder Equity40,923
 As reported
Total Liabilities 9,774
Total Stockholder Equity+ 40,923
Total Assets = 50,697

Assets

Total Assets50,697
Total Current Assets50,221
Long-term Assets476
Total Current Assets
Cash And Cash Equivalents 14,331
Short-term Investments 34,167
Other Current Assets 1,723
Total Current Assets  (as reported)50,221
Total Current Assets  (calculated)50,221
+/-0
Long-term Assets
Property Plant Equipment 476
Long-term Assets  (as reported)476
Long-term Assets  (calculated)476
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities9,774
Long-term Liabilities0
Total Stockholder Equity40,923
Total Current Liabilities
Short-term Debt 475
Accounts payable 1,001
Other Current Liabilities 8,298
Total Current Liabilities  (as reported)9,774
Total Current Liabilities  (calculated)9,774
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock2
Retained Earnings -140,564
Accumulated Other Comprehensive Income -78
Other Stockholders Equity 181,563
Total Stockholder Equity (as reported)40,923
Total Stockholder Equity (calculated)40,923
+/-0
Other
Capital Stock2
Cash and Short Term Investments 48,498
Common Stock Shares Outstanding 23,925
Liabilities and Stockholders Equity 50,697
Net Debt -13,856
Net Invested Capital 40,923
Net Working Capital 40,447
Property Plant and Equipment Gross 476
Short Long Term Debt Total 475



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
56,238
123,630
120,722
115,948
108,952
100,643
90,513
80,659
70,616
79,684
66,223
58,864
50,697
50,69758,86466,22379,68470,61680,65990,513100,643108,952115,948120,722123,63056,238000
   > Total Current Assets 
0
0
0
55,362
123,630
120,689
115,299
108,384
100,159
90,146
79,792
69,838
78,960
65,592
58,323
50,221
50,22158,32365,59278,96069,83879,79290,146100,159108,384115,299120,689123,63055,362000
       Cash And Cash Equivalents 
0
0
0
55,316
120,851
90,861
75,461
66,346
35,037
27,716
18,745
10,775
25,121
19,504
23,910
14,331
14,33123,91019,50425,12110,77518,74527,71635,03766,34675,46190,861120,85155,316000
       Short-term Investments 
0
0
0
0
0
27,980
37,098
40,379
61,087
59,702
58,574
56,814
51,005
43,543
32,106
34,167
34,16732,10643,54351,00556,81458,57459,70261,08740,37937,09827,98000000
       Other Current Assets 
0
0
0
46
2,779
1,848
2,740
1,659
4,035
2,728
2,473
2,249
2,834
2,545
2,307
1,723
1,7232,3072,5452,8342,2492,4732,7284,0351,6592,7401,8482,77946000
   > Long-term Assets 
0
0
0
876
0
33
649
568
484
367
867
778
724
631
541
476
476541631724778867367484568649330876000
       Property Plant Equipment 
0
0
0
0
0
0
616
535
451
367
834
745
689
596
505
476
476505596689745834367451535616000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
33
33
35
35
0
0
00353533330000000000
       Other Assets 
0
0
0
876
0
33
33
33
33
0
33
33
0
35
0
0
0035033330333333330876000
> Total Liabilities 
0
0
0
3,135
4,044
3,273
4,296
5,629
6,778
7,544
8,622
9,146
7,551
8,115
6,820
9,774
9,7746,8208,1157,5519,1468,6227,5446,7785,6294,2963,2734,0443,135000
   > Total Current Liabilities 
0
0
0
3,135
4,044
3,273
4,021
5,444
6,684
7,544
8,153
8,764
7,239
7,901
6,712
9,774
9,7746,7127,9017,2398,7648,1537,5446,6845,4444,0213,2734,0443,135000
       Short-term Debt 
0
0
0
0
0
0
328
339
350
363
360
358
371
375
394
475
475394375371358360363350339328000000
       Accounts payable 
0
0
0
1,213
2,019
915
891
1,028
1,357
602
575
1,310
283
1,939
363
1,001
1,0013631,9392831,3105756021,3571,0288919152,0191,213000
       Other Current Liabilities 
0
0
0
1,922
2,025
2,358
328
339
4,977
6,579
7,218
7,096
6,585
5,962
6,349
8,298
8,2986,3495,9626,5857,0967,2186,5794,9773393282,3582,0251,922000
   > Long-term Liabilities 
0
0
0
0
0
0
275
185
94
965
469
382
312
214
108
0
010821431238246996594185275000000
       Deferred Long Term Liability 
0
0
0
876
0
0
0
0
0
0
0
0
0
0
0
0
000000000000876000
> Total Stockholder Equity
0
0
0
53,103
119,586
117,449
111,652
103,323
93,865
82,969
72,037
61,470
72,133
58,108
52,044
40,923
40,92352,04458,10872,13361,47072,03782,96993,865103,323111,652117,449119,58653,103000
   Common Stock
0
0
0
0
1
1
1
1
1
1
1
1
2
2
2
2
2222111111110000
   Retained Earnings Total Equity00-112,597-97,598-86,142-74,7970000-27,079-20,0990000
   Accumulated Other Comprehensive Income -78-181-290-421-692-915-784-596-164-24-34-123,6300000
   Capital Surplus 
0
0
0
0
139,684
144,561
0
0
0
0
147,748
148,303
170,150
170,993
0
0
00170,993170,150148,303147,7480000144,561139,6840000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
11,708
139,684
23,839
29,151
145,683
146,254
146,953
147,748
148,303
170,150
170,993
177,754
181,563
181,563177,754170,993170,150148,303147,748146,953146,254145,68329,15123,839139,68411,708000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-5
Gross Profit-5-5
 
Operating Income (+$)
Gross Profit-5
Operating Expense-56,754
Operating Income-56,759-56,759
 
Operating Expense (+$)
Research Development43,752
Selling General Administrative13,007
Selling And Marketing Expenses5
Operating Expense56,75456,764
 
Net Interest Income (+$)
Interest Income2,229
Interest Expense-0
Other Finance Cost-0
Net Interest Income2,229
 
Pretax Income (+$)
Operating Income-56,759
Net Interest Income2,229
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-54,422-59,096
EBIT - interestExpense = -56,759
-54,422
-54,422
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-56,759-54,422
Earnings Before Interest and Taxes (EBITDA)-56,754
 
After tax Income (+$)
Income Before Tax-54,422
Tax Provision-0
Net Income From Continuing Ops-50,734-54,422
Net Income-54,422
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses56,759
Total Other Income/Expenses Net2,337-2,229
 

Technical Analysis of Longboard Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Longboard Pharmaceuticals Inc. The general trend of Longboard Pharmaceuticals Inc is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Longboard Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Longboard Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 17.50 < 17.81 < 20.89.

The bearish price targets are: 10.29 > 9.84 > 8.98.

Tweet this
Longboard Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Longboard Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Longboard Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Longboard Pharmaceuticals Inc. The current macd is -0.66812751.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Longboard Pharmaceuticals Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Longboard Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Longboard Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Longboard Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartLongboard Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Longboard Pharmaceuticals Inc. The current adx is 12.43.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Longboard Pharmaceuticals Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Longboard Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Longboard Pharmaceuticals Inc. The current sar is 20.71.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Longboard Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Longboard Pharmaceuticals Inc. The current rsi is 41.36. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Longboard Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartLongboard Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Longboard Pharmaceuticals Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Longboard Pharmaceuticals Inc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Longboard Pharmaceuticals Inc Daily Stochastic Oscillator ChartLongboard Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Longboard Pharmaceuticals Inc. The current cci is -87.0041202.

Longboard Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartLongboard Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Longboard Pharmaceuticals Inc. The current cmo is -20.31329149.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Longboard Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartLongboard Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Longboard Pharmaceuticals Inc. The current willr is -79.49308756.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Longboard Pharmaceuticals Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Longboard Pharmaceuticals Inc Daily Williams %R ChartLongboard Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Longboard Pharmaceuticals Inc.

Longboard Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Longboard Pharmaceuticals Inc. The current atr is 1.35297578.

Longboard Pharmaceuticals Inc Daily Average True Range (ATR) ChartLongboard Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Longboard Pharmaceuticals Inc. The current obv is 50,031,590.

Longboard Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartLongboard Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Longboard Pharmaceuticals Inc. The current mfi is 39.53.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Longboard Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartLongboard Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Longboard Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Longboard Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Longboard Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.357
Ma 20Greater thanMa 5019.083
Ma 50Greater thanMa 10020.081
Ma 100Greater thanMa 20017.276
OpenGreater thanClose17.690
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Longboard Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Longboard Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Longboard Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Longboard Pharmaceuticals Inc

I send you an email if I find something interesting about Longboard Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Longboard Pharmaceuticals Inc.

Receive notifications about Longboard Pharmaceuticals Inc in your mailbox!